ArticleACS medicinal chemistry letters2021

Development of Highly Potent and Selective Pyrazolopyridine Inhibitor of CDK8/19.

John M Hatcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.